Related Experiment Video
Updated: May 15, 2026

Acupoint Application Combined with Acupressure as an Adjunctive Therapy for Chemotherapy-Induced Nausea and Vomiting
Published on: June 21, 2024
N-acetylcysteine in bulimia nervosa--open-label trial
Anna I Guerdjikova1, Thomas J Blom, Nicole Mori
1Lindner Center of HOPE, Mason, OH 45040, USA. anna.guerdjikova@lindnercenter.org
Abstract:
The objective of this 12-week open-label flexible-dose study was to preliminarily assess the effectiveness of N-acetylcysteine (NAC) in bulimia nervosa (BN). The primary outcome was binge-purge episode frequency. Eight individuals with BN by DSM-IV criteria received NAC, but only two completed the study. NAC was not associated with significant reductions in frequency of binge-purge episodes or measures of clinical severity, eating, or mood pathology. In this trial, NAC was ineffective in BN and was associated with a high discontinuation rate.
Related Concept Videos
Bulimia Nervosa
Prevention of Further Absorption of Poison
Drugs for Treatment of Constipation-Predominant IBS
Binge Eating Disorders
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists